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Summary
Pluripotent embryonic cells become progressively lineage
restricted during development in a process that culminates
in the differentiation of stable organ-specific cell types that
perform specialized functions. Terminally differentiated
pancreatic acinar cells do not have the innate capacity to
contribute to the endocrineb cell lineage, which is destroyed
in individuals with autoimmune diabetes [1]. Some cell types
can be reprogrammed using a single factor [2, 3], whereas
other cell types require continuous activity of transcriptional
regulators to repress alternate cell fates [4–6]. Thus, we
hypothesized that a transcriptional network continuously
maintains the pancreatic acinar cell fate. We found that
postembryonic antagonism of Ptf1a, a master regulator of
pancreatic development [7] and acinar cell fate specification
[8, 9], induced the expression of endocrine genes including
insulin in the exocrine compartment. Using a genetic lineage
tracing approach, we show that the induced insulin+ cells
are derived from acinar cells. Cellular reprogramming
occurred under homeostatic conditions, suggesting that
the pancreatic microenvironment is sufficient to promote
endocrine differentiation. Thus, severe experimental manip-
ulations [10, 11]may not be required to potentiate pancreatic
transdifferentiation. These data indicate that targeted
postembryonic disruption of the acinar cell fate can restore
the developmental plasticity that is lost during development.
Results and Discussion
The pancreas is derived from a dorsal and a ventral bud of
endodermal tissue, which together generate endocrine and
exocrine cell types [12]. In zebrafish, the acinar cells are
exclusively derived from the ventral pancreatic bud [13]. To
analyze the temporal differentiation of acinar cells, we exam-
ined pancreatic markers at multiple time points in Tg
(ptf1a:eGFP) [14] zebrafish. The Tg(ptf1a:eGFP) bacterial
artificial chromosome reporter marks the ventral pancreatic
bud by 32 hours postfertilization (hpf) [8, 15]. At 36 hpf, Tg
(ptf1a:eGFP)-expressing cells formed a homogeneous field
and coexpressed the homeodomain transcription factors
Prox1 and Nkx6.1 (Figures 1A–1B0; [8]). Coexpression of these
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at 36 hpf. By 60 hpf, Nkx6.1 and Tg(ptf1a:eGFP) were
expressed in mutually exclusive domains (Figures 1C and
1C0) and Prox1 was no longer detected in the pancreas
(Figures 1D and 1D0). However, Tg(ptf1a:eGFP)-expressing
cells were not fully differentiated by 60 hpf, because they did
not coexpress the acinar cell marker Elastase (Figures 1E
and 1E0). Zebrafish embryonic development (0–72 hpf) is
fueled by the absorption of the maternally deposited yolk.
After the embryonic-to-larval transition at 72 hpf, a functional
digestive system becomes necessary to process external
nutrient sources [16]. Consistent with this requirement,
Elastase was cytoplasmically localized (Figures 1F and 1F0)
and packaged into secretory granules on the luminal surface
of Tg(ptf1a:eGFP) cells (Figure 1F0 inset) by 84 hpf. Our results
are consistent with ultrastructural studies that have shown
that acinar cell cytodifferentiation after 72 hpf coincides with
the expression of acinar cell markers [17]. Because Ptf1a
expression becomes restricted to acinar cells in the devel-
oping mouse pancreas [18], we predicted that coexpression
of Tg(ptf1a:eGFP) and Elastase would coincide with cell fate
commitment of the pancreatic progenitor pool. Consistent
with this prediction, Tg(ptf1a:eGFP) expression was excluded
from the Nkx6.1-positive intrapancreatic ducts (Figures 1G
and 1G0) and the Islet-1-positive endocrine compartment
(Figures 1H and 1H0) at 84 hpf. We conclude that the multipo-
tent pancreatic primordium gives rise to terminally differenti-
ated exocrine and endocrine cell types by 84 hpf.
During embryogenesis (0–72 hpf), the level of Ptf1a activity
influences the fate of pancreatic cells: high levels of Ptf1a
activity promote exocrine cell fates, whereas low levels of
Ptf1a activity are compatible with endocrine differentiation
[8]. Ptf1a activity requires assembly of the tripartite PTF1
complex, which consists of Ptf1a, an E protein, and RBPJ(L)
and directly activates exocrine target gene expression [19].
In addition, the PTF1 complex autoregulates the Ptf1a
promoter, resulting in sustained expression of high levels of
Ptf1a in acinar cells [20]. To further address the function of
PTF1, we generated an Engrailed-Ptf1a fusion protein, in
whichwe fused the Engrailed transcriptional repressor domain
to the amino terminus of the full-length Ptf1a protein. The
Engrailed repressor domain recruits chromatin-modifying
complexes to repress target gene transcription [21]. To
explore the regulation of PTF1 targets, we generated a stable
cell line that expresses luciferase under the control of a tandem
array of PTF1 binding sites in human embryonic kidney 293
cells, which require exogenous Ptf1a to form a PTF1 complex
[22] (Figure 2A). We found that Engrailed-Ptf1a repressed the
transcriptional activity of wild-type Ptf1a in a dose-dependent
manner (Figure 2B). Our results suggest that overexpression of
Engrailed-Ptf1a antagonizes transcription initiation at Ptf1a
binding sites and permits only low-level transcription of
PTF1 target genes.
To test whether PTF1 activity is required to maintain acinar
cell fate in vivo, we employed the heat-inducible overexpres-
sion of transgenes in a cre-restricted domain (HOTcre) system
[15] to express the Engrailed-Ptf1a fusion protein specifically
in acinar tissue (Figure 3A). We placed the Cre recombinase
Figure 1. ptf1a Expression Becomes Restricted
to Differentiated Acinar Cells during Early Larval
Development
Embryos express Tg(ptf1a:eGFP) in the pancre-
atic domain. Expression of pancreatic markers
was analyzed by immunofluorescence. Scale
bars represent 20 mm.
(A–B0) Confocal projections of pancreatic tissue
at 36 hours postfertilization (hpf).
(C–H0) Confocal sections of pancreatic tissue at
60 (C–E0) and 84 hpf (F–H0). Dotted lines delineate
Tg(ptf1a:eGFP)-expressing tissue.
(A–B0) Tg(ptf1a:eGFP)-expressing cells initially
coexpress Nkx6.1 and Prox1.
(C–D0) By 60 hpf, Nkx6.1 (C and C0, arrows) and
Prox1 (D and D0) become excluded from the Tg
(ptf1a:eGFP) expression domain.
(E–F0) Coexpression of Tg(ptf1a:eGFP) with the
acinar cell marker Elastase (Ela) is detected by
84 hpf. Elastase-positive granules are detected
on the apical surface of acinar cells (F0, arrow-
head), adjacent to Tg(ptf1a:eGFP)-negative intra-
pancreatic cells (F, arrows).
(G–H0) The duct marker Nkx6.1 (G and G0) and
the endocrine marker Isl1 (H and H0) appear to
be restricted to Tg(ptf1a:eGFP)-negative ductal
and islet cells respectively by 84 hpf. Isl1 is
also expressed in the pancreatic mesenchyme
(H and H0, arrows).
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control over gene expression. We used the hsp70l promoter to
control the temporal expression of the Engrailed-Ptf1a fusion
protein in cells that had undergone a Cre-mediated excision
event. For simplicity, we will refer to this double-transgenic
line as elastase:cre-Ptf1aEN (Figure 3A).
To determine whether Tg(ela3l:cre) specifically marked
differentiated acinar cells, we heat shocked Tg(ela3l:cre);
Tg(hsp70l:loxP:mCherrySTOP:loxP:H2B-GFP) double-trans-
genic embryos, which induced H2B-GFP expression in cells
that had undergone Cre-mediated recombination. When the
double-transgenic embryos were heat shocked at 60 hpf,
a time point before the onset of elastase expression (Fig-
ure 1E0), H2B-GFP expression was not detected in the
pancreas at 84 hpf (Figures 3B and 3B0). However, when the
double transgenics were heat shocked during larval develop-
ment at 4.5 days postfertilization (dpf), at least 24 hr after the
onset of Elastase expression (Figure 1F0), broad expression
of H2B-GFP was observed specifically in the pancreatic
domain at 5.5 dpf (Figures 3C and 3C0). Heat-shock-induced
expression of Tg(hsp70l:loxP:mCherrySTOP:loxP:H2B-GFP)
was observed throughout the exocrine compartment in Tg
(ela3l:cre)-negative controls (see Figure S1 available online).
The cells that expressed H2B-GFP after heat induction at
4.5 dpf coexpressed Elastase (Figures 3D and 3D0, arrow;
n = 10 animals) but did not coexpress the b cell marker
Insulin (Figures 3E and 3E0; n = 10 animals) at 5.5 dpf. We
conclude that Tg(ela3l:cre) specifically marks differentiated
acinar cells.Next, we asked whether overexpres-
sion of Engrailed-Ptf1a impacted the
gene expression profile of differentiated
acinar cells. We crossed elastase:cre-
Ptf1aEN to reporter fish for both the
acinar cell marker Tg(ela3l:eGFP) [23]and the b cell marker Tg(insulin:dsRED) [24]. Heat-shock
induction of elastase:cre-Ptf1aEN at 4.5 dpf resulted in
mosaic expression of Tg(ela3l:eGFP) at 6.5 dpf (Figure 3F0
inset). Because the half-life of eGFP in cells is w24 hr [25],
Tg(ela3l:eGFP) expression was likely downregulated shortly
after elastase:cre-Ptf1aEN induction. This observation is
consistent with the dominant-negative activity exhibited by
Engrailed-Ptf1a in vitro (Figure 2B). In contrast, Tg(ela3l:
eGFP) expression was uniform in Tg(ela3l:cre)-negative
controls (Figure 3G). Strikingly, a subset of cells (3–10 per
animal, n = 20) that exhibited low levels of Tg(ela3l:eGFP)
expression also expressed Tg(insulin:dsRED) (Figure 3F
inset); the origin of these insulin+ cells is discussed below.
Tg(insulin:dsRED) expression was not observed in cells
that expressed high levels of Tg(ela3l:eGFP) (Figure 3F) or
in Tg(ela3l:cre)-negative controls (Figure 3G0). To determine
whether acinar cells might have acquired a pluripotent endo-
crine progenitor fate prior to activating Tg(insulin:dsRED),
we analyzed the expression of the Tg(pax6b:eGFP)
panendocrine progenitor reporter [26] 1 day after elastase:
cre-Ptf1aEN heat-shock induction (Figures 3H–3I0). elastase:
cre-Ptf1aEN larvae exhibited broad low-level expression of
Tg(pax6b:eGFP) throughout the pancreas (compare Figures
3H0 and 3I0). In addition, scattered cells outside of the islet
expressed high levels of Tg(pax6b:eGFP) (Figures 3H and
3H0, arrows). In contrast, Tg(pax6b:eGFP) expression was
only observed in the extrapancreatic duct and principal islet
in Tg(ela3l:cre)-negative controls (Figures 3I and 3I0, arrow-
heads). To further investigate the fate of cells that expressed
Figure 2. Engrailed-Ptf1a Exhibits Dose-Dependent Antagonism of Wild-
Type Ptf1a Activity
(A) A stable cell line (293-33RBPJ-Luc) was generated in which luciferase
was placed under the control of RBPJ binding sites.
(B) Normalized luminescence of 293-33RBPJ-Luc cells transfected with
Ptf1a and/or Ptf1aEN (mean 6 standard deviation). *p < 0.05; **p < 0.01.
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714Tg(pax6b:eGFP), we analyzed glucagon expression using
Tg(gcga:GFP) [27], a marker of a cell fate, after elastase:
cre-Ptf1aEN induction. As with the expression of Tg(insu-
lin:dsRED) (Figure 3F), we observed a small number of
glucagon+ cells in the exocrine compartment of animals
that expressed elastase:cre-Ptf1aEN (Figures 3J and 3J0; 4–
12 cells per animal, n = 20), and we did not observe
glucagon+ cells outside of the principal islet in Tg(ela3l:
cre)-negative controls (Figures 3K and 3K0). Thus, elastase:
cre-Ptf1aEN expression altered the gene expression profile
of many exocrine cells, but only a subset of these cells
initiated an endocrine gene expression program.
There are at least twopossible origins for the ectopic insulin+
cells (Figure 3F). A formal possibility is that elastase:
cre-Ptf1aEN acts cell nonautonomously to induce partial
differentiation toward both acinar and endocrine cell fates
in a small population of pancreatic progenitors. A second
possibility is that acinar cells downregulate Tg(ela3l:eGFP)
and upregulate Tg(insulin:dsRED) expression. To distinguish
between these possibilities, we developed a genetic
lineage tracing approach to mark acinar cells that activated
insulin expression. We generated animals that expressed
Tg(insulin:loxP:mCherrySTOP:loxP:H2B-GFP) to specifically
label with H2B-GFP insulin+ cells that derived from a
lineage that expressed Tg(ela3l:cre) (Figure 4A). insulin+ cells
derived from lineages that did not express Tg(ela3l:cre) will
exhibit mCherry expression. In Tg(ela3l:cre);Tg(insulin:loxP:mCherrySTOP:loxP:H2B-GFP) animals, b cells in the principal
islet exhibited mCherry expression at 6.5 dpf (Figures 4B
and 4B00), whereas H2B-GFP expression was not observed
(Figures 4B and 4B0; n > 20 animals). Therefore, in wild-type
animals, b cells did not derive from acinar cells. However, after
elastase:cre-Ptf1aEN induction at 4.5 dpf, H2B-GFP expres-
sion was detected in cells scattered throughout the exocrine
compartment of the pancreas (4–10 cells per animal, n = 20;
Figures 4C–4C 00, arrows). H2B-GFP expression was not
observed in Ptf1aEN-negative controls (Figures 4D–4D00;
n > 20 animals). We conclude that elastase:cre-Ptf1aEN can
cell-autonomously induce the conversion of acinar cells into
an insulin+ cell type.
To determine whether acinar cell maturation affects
lineage plasticity, we repeated the lineage tracing experi-
ments in older animals. A less intense heat-shock induction
protocol was used because older animals were more heat
sensitive (see Experimental Procedures). Following elastase:
cre-Ptf1aEN induction at 14 dpf, H2B-GFP was detected
in the exocrine compartment in most animals 2 days later
(0–2 cells per animal, n = 10; Figures 4E–4E00, arrow), whereas
H2B-GFP expression was not observed in Ptf1aEN-negative
controls (data not shown). By 21 dpf, acinar cells appeared
to be resistant to Ptf1aEN-mediated cell type conversion
(data not shown). Thus, higher levels of Ptf1aEN might
be required after 14 dpf to disrupt acinar cell fate, or
maturing acinar cells might activate additional maintenance
mechanisms.
It has been shown that inflammation in response to adeno-
viral packaging proteins is essential for cellular reprogramming
of liver cells to pancreatic endocrine fates [28]. It is unclear
whether inflammation isbroadly required for in vivo reprogram-
ming of other cell types. By the onset of larval development
(72 hpf), the zebrafish innate immune system can infiltrate
tissues in response to injury and infection [29]. We predicted
that genetically encoded elastase:cre-Ptf1aEN expression
did not initiate an immune response. However, it is possible
that antagonism of normal acinar cell function or the endoge-
nous heat-shock response could result in pancreatic injury
and inflammation as a result of the inappropriate release of
digestive enzymes. To address this possibility, we induced
elastase:cre-Ptf1aEN expression in a Tg(mpx:GFP) back-
ground, which marks granulocytes during larval development
[30]. In response to physical injury, zebrafish granulocytes
immediately exhibit chemotaxis toward the wound and accu-
mulate within the target tissue by 2 hr postinjury [31]. We
analyzed pancreatic granulocytes at 2 hr (Figures S2A and
S2B) and 24 hr after heat shock (data not shown) to determine
whether heat-shock treatment or elastase:cre-Ptf1aEN
induction triggered an inflammatory response. The number
of pancreatic granulocytes was unchanged at both time
points in elastase:cre-Ptf1aEN animals compared to Tg(ela3l:
cre)-negative controls (Figure S2C), suggesting that
Engrailed-Ptf1a-induced cell fate conversion does not involve
an inflammatory response.
In conclusion, we have identified a novel mechanism that
induces conversion of acinar cells to endocrine fates under
homeostatic conditions. Our data support a model in which
cues from the pancreatic microenvironment can reprogram
acinar cells with low levels of Ptf1a activity into hormone-
expressing cells. Thus, if targeted knockdown of Ptf1a
phenocopies Ptf1a antagonism, emerging methods for
tissue-specific delivery of small interfering RNAs [32, 33]
could potentiate b cell regeneration therapy.
Figure 3. Inhibition of Ptf1a Activity Induces
Ectopic Endocrine Gene Expression
(A) elastase:cre-Ptf1aEN, heat-inducible overex-
pression of Engrailed-Ptf1a in an elastase3l:Cre-
restricted domain. Expression of Cre in acinar
cells excises the EBFP2-STOP cassette and
permits heat-inducible expression of Engrailed-
Ptf1a.
(B–K0) Confocal sections through pancreata
marked with immunofluorescence (D–E0) or fluo-
rescent transgenes (F–K0). Scale bars represent
20 mm.
(B–E0) Tg(ela3l:cre);(hsp70l:loxP:mCherrySTOP:
loxP:H2B-GFP) embryos were heat shocked at
60 hpf (B and B0) or 4.5 days postfertilization
(dpf) (C–E0) and analyzed 24 hr after heat shock.
(B and B0) Tg(ela3l:cre) did not mark pancreatic
cells by 60 hpf (dotted outline).
(C and C0) By 4.5 dpf, Tg(ela3l:cre)marked a large
fraction of pancreatic cells (dotted outline).
(D–E0) Cells that were marked by Tg(ela3l:cre) at
4.5 dpf coexpressed the acinar marker Elastase
(D and D0, arrow) but did not coexpress the endo-
crine marker Insulin (E and E0) at 5.5 dpf.
(F–I0) elastase:cre-Ptf1aEN (F, F0, H, H0, J, and J0)
and Tg(ela3l:cre)-negative control embryos (G,
G0, I, I0, K, and K0) were heat shocked at 4.5 dpf
and analyzed at 5.5 (H–I0) or 6.5 dpf (F–G0 and
J–K0).
(F and F0) elastase:cre-Ptf1aEN induction caused
downregulation of Tg(elastase:eGFP) expression
in a subset of acinar cells (F0, inset). Some acinar
cells that expressed low levels of Tg(elasta-
se:eGFP) coexpressed Tg(insulin:dsRED) (F,
inset).
(G and G0) Tg(insulin:dsRED) expression was not
detected in Tg(ela3l:cre)-negative controls.
(H–I0) elastase:cre-Ptf1aEN expression induced
expression of the endocrine progenitor marker
Tg(pax6b:eGFP) in cells outside of the principal
islet (H and H0, arrows). In Tg(ela3l:cre)-negative
controls at this stage, Tg(pax6b:eGFP) was ex-
pressed in the principal islet and in endocrine
cells that differentiated in the extrapancreatic
duct (I and I0, arrowheads).
(J–K0) elastase:cre-Ptf1aEN also induced Tg
(gcga:GFP) expression in the exocrine compart-
ment (J and J0), whereas Tg(gcga:GFP) expres-
sion was restricted to the principal islet in Tg
(ela3l:cre)-negative controls (K and K0).
See also Figure S1.
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Figure 4. Genetic Lineage Tracing of Acinar to insulin+ Cell Fate Conversion
(A) Tg(ela3l:cre);Tg(insulin:loxP:mCherrySTOP:loxP:H2B-GFP) lineage trac-
ing. Expression of Cre in acinar cells excises the mCherry-STOP cassette
and permits expression of H2B-GFP in cells that activate the insulin
promoter.
(B–E00) Confocal sections through pancreata marked with fluorescent trans-
genes and TO-PRO to mark DNA. Scale bars represent 20 mm.
(B–B00) Tg(ela3l:cre);Tg(insulin:loxP:mCherrySTOP:loxP:H2B-GFP) did not
mark any pancreatic cells in wild-type animals.
(C–D00) elastase:cre-Ptf1aEN expression induced scattered H2B-GFP-posi-
tive cells throughout the pancreatic domain (arrows) (C–C00), which were not
induced in Ptf1aEN-negative controls (D–D00).
(E–E00) elastase:cre-Ptf1aEN expression induced isolated H2B-GFP-positive
cells at 14 dpf (arrow).
See also Figure S2.
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Zebrafish Strains and Lines
Zebrafish were raised under standard laboratory conditions at 28C. Heat
shocks before 5 dpf were performed at 39.5C for 25 min. Heat shocks
after 5 dpf were performed at 38.5C for 25 min. We used the following
lines: Tg(ptf1a:eGFP)jh1 [14], Tg(ela3l:Cre;cryaa:Venus)s932;Tg(hsp70l:loxP-
EBFP2-STOP-loxP-Ptf1aEN;cryaa:Cerulean)s933 (defined here as ‘‘elastase:
cre-Ptf1aEN’’), Tg(hsp70l:loxP-mCherry-STOP-loxP-H2B-GFP;cryaa:
Cerulean)s923 [15], Tg(ela3l:GFP)gz2 [23], Tg(ins:dsRed)m1018 [24], Tg(P0-
pax6b:GFP)ulg515 [26], Tg(gcga:GFP)ia1 [27], Tg(insulin:loxP:mCherrySTOP:
loxP:H2B-GFP;cryaa:Cerulean)s934, and Tg(mpx:GFP)i114 [30].
DNA Constructs and Transgenic Lines
ela3l:Cre;cryaa:Venus was generated by placing the Cre coding sequence
downstream of 2.9 kb of the proximal ela3l promoter. The cryaa:Venus
cassette was inserted downstream of Cre in the reverse orientation using
0.54 kb of the cryaa promoter [34]. hsp70l:loxP-EBFP2-STOP-loxP-
Ptf1aEN;cryaa:Cerulean was constructed by sequentially replacing
mCherry and H2B-GFP fragments in hsp70l:loxP-mCherry-STOP-loxP-
H2B-GFP;cryaa:Cerulean [15] with EBFP2-STOP and Ptf1aEN, respectively.
insulin:loxP:mCherrySTOP:loxP:H2B-GFP;cryaa:Cerulean was constructed
by replacing the hsp70l promoter in hsp70l:loxP-mCherry-STOP-loxP-H2B-
GFP;cryaa:Cerulean with 1.5 kb of the proximal insulin promoter. All
constructs were generated in a pBluescript backbone that contains I-SceI
meganuclease sites. Multiple transgenic lines were established for each
construct using the I-SceI meganuclease method as described previously
[35]. A single representative transgenic line for each construct was used
for all experiments.
Immunofluorescence and Confocal Microscopy
Antibody staining was performed as described previously [36] using the
following antibodies: Islet-1 (1:100, DSHB clone 39.4D5), Nkx6.1 (1:100,
DSHB clone F55A10), Prox1 (1:1000, Millipore AB5474), Elastase (1:200,
Millipore AB1216), and Alexa secondary antibodies (1:500, Invitrogen).
Cell nuclei were visualized with TO-PRO-3 (1:2000, Invitrogen T3605). All
confocal sections and Z stacks were acquired on a Zeiss LSM 5 Pascal
microscope and processed in ImageJ.
Generation of 293-33RBPJ-Luc Cell Line
A fragment containing three 32 bp PTF1 binding sites from the mouse Rbpjl
promoter upstream of a minimal Ela1 promoter (292 to +8) [22] was subcl-
oned into the luciferase reporter vector pGL4.17 (Promega). Following
transfection, 293 cells that contained stable integrations were selected
using 800 mg/ml G418. A single representative line that exhibited low levels
of basal luciferase expression was used for all experiments.
Luciferase Assay
293-33RBPJ-Luc cells were plated at 80% confluence in 96-well plates and
transfected with 40 ng total DNA/well and 1 ml Lipofectamine transfection
reagent (Invitrogen) in 75 ml serum free Dulbecco’smodified Eagle’smedium
(DMEM). After 4 hr, the medium was replaced with DMEM containing 10%
fetal bovine serum. Each transfection contained 10 ng renilla (pRL-TK,
Promega) and variable amounts of mouse Ptf1a (pcDNA3.1/Ptf1a) and/or
mouse Ptf1a-Engrailed (pcDNA3.1/Ptf1aEN) expression plasmids. An
empty expression vector (pcDNA3.1, Invitrogen) was used to normalize
the total amount of DNA per well. Two days posttransfection, cells were
analyzed for luciferase and renilla activity using the Dual-Glo reporter assay
system (Promega) per the manufacturer’s protocol.
Supplemental Information
Supplemental Information includes two figures and can be found with this
article online at doi:10.1016/j.cub.2011.03.041.
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